1. III. Treating dyslipidemias
American Journal of Kidney Diseases 
Volume 41, Pages S39-S58 (April 2003)
DOI: /S (03)

2. Fig 7
The approach to treatment of dyslipidemias in adults with chronic kidney disease used in these guidelines. Units are in mg/dL. To convert mg/dL to mmol/L, multiply triglycerides by and LDL or non-HDL cholesterol by Abbreviations: TG, triglycerides; TLC, therapeutic lifestyle changes; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
American Journal of Kidney Diseases  , S39-S58DOI: ( /S (03) )

3. Fig 8
The approach to treatment of dyslipidemias in adolescents with chronic kidney disease used in these guidelines. Units are in mg/dL. To convert mg/dL to mmol/L, multiply triglycerides by and LDL or non-HDL cholesterol by Abbreviations: TG, triglycerides; TLC, therapeutic lifestyle changes; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
American Journal of Kidney Diseases  , S39-S58DOI: ( /S (03) )

4. Fig 9
Expected responses to treatment of low-density lipoprotein (upper panel), high-density lipoprotein (middle panel), and triglycerides (lower panel), based on studies in the general population.3
American Journal of Kidney Diseases  , S39-S58DOI: ( /S (03) )